| As Of | Filing | | Doc. | | Page | | Title | Docs. |
|---|
| | |  |
| 1/2/24 | | SC 13G/A | | | | 1 | | ( (iv) Shared power to dispose or to direct the disposition of 0 [ re: RedHill Biopharma Ltd. ] | 1 |
| 1/2/24 | | SC 13G/A | | | | 1 | | ( (iv) Shared power to dispose or to direct the disposition of 0 [ re: Huadi International Group Co., Ltd. ] | 1 |
| 1/2/24 | | SC 13G/A | | | | 1 | | ( (iv) Shared power to dispose or to direct the disposition of 0 [ re: Kiromic Biopharma, Inc. ] | 1 |
| 1/2/24 | | SC 13G/A | | | | 1 | | ( (iv) Shared power to dispose or to direct the disposition of 1,842,070 [ re: Toughbuilt Industries, Inc. ] | 1 |
| 1/4/24 | | SC 13G | | | | 1 | | ( (iv) Shared power to dispose or to direct the disposition of 10,006,584 [ re: Phunware, Inc. ] | 1 |
| 1/3/24 | | SC 13G | | | | 1 | | ( (iv) Shared power to dispose or to direct the disposition of 144,867 [ re: Mobiquity Technologies, Inc. ] | 1 |
| 1/3/24 | | SC 13G | | | | 1 | | ( (iv) Shared power to dispose or to direct the disposition of 177,513 [ re: Bluejay Diagnostics, Inc. ] | 1 |
| 1/2/24 | | SC 13G/A | | | | 1 | | ( (iv) Shared power to dispose or to direct the disposition of 182,249 [ re: Pulmatrix, Inc. ] | 1 |
| 1/3/24 | | SC 13G | | | | 1 | | ( (iv) Shared power to dispose or to direct the disposition of 2,087,130 [ re: GlucoTrack, Inc. ] | 1 |
| 1/4/24 | | SC 13G | | | | 1 | | ( (iv) Shared power to dispose or to direct the disposition of 200,303 [ re: iBio, Inc. ] | 1 |
| 1/2/24 | | SC 13G/A | | | | 1 | | ( (iv) Shared power to dispose or to direct the disposition of 220,663 [ re: Scinai Immunotherapeutics Ltd. ] | 1 |
| 1/3/24 | | SC 13G | | | | 1 | | ( (iv) Shared power to dispose or to direct the disposition of 3,452,342 [ re: Recon Technology, Ltd. ] | 1 |
| 1/3/24 | | SC 13G | | | | 1 | | ( (iv) Shared power to dispose or to direct the disposition of 403,233 [ re: Revelation Biosciences, Inc. ] | 1 |
| 1/2/24 | | SC 13G/A | | | | 1 | | ( (iv) Shared power to dispose or to direct the disposition of 452,751 [ re: Neptune Wellness Solutions Inc. ] | 1 |
| 1/3/24 | | SC 13G | | | | 1 | | ( (iv) Shared power to dispose or to direct the disposition of 5,205,348 [ re: Tonix Pharmaceuticals Holding Corp. ] | 1 |
| 1/4/24 | | SC 13G | | | | 1 | | ( (iv) Shared power to dispose or to direct the disposition of 5,322,048 [ re: Cyngn Inc. ] | 1 |
| 1/3/24 | | SC 13G | | | | 1 | | ( (iv) Shared power to dispose or to direct the disposition of 5,338,587 [ re: Treasure Global Inc. ] | 1 |
| 1/3/24 | | SC 13G | | | | 1 | | ( (iv) Shared power to dispose or to direct the disposition of 524,972 [ re: InMed Pharmaceuticals Inc. ] | 1 |
| 1/3/24 | | SC 13G | | | | 1 | | ( (iv) Shared power to dispose or to direct the disposition of 579,814 [ re: Lipella Pharmaceuticals Inc. ] | 1 |
| 1/3/24 | | SC 13G | | | | 1 | | ( (iv) Shared power to dispose or to direct the disposition of 600,427 [ re: Fangdd Network Group Ltd. ] | 1 |
| 1/2/24 | | SC 13G/A | | | | 1 | | ( (iv) Shared power to dispose or to direct the disposition of 63,636 [ re: Dogness (International) Corp. ] | 1 |
| 1/2/24 | | SC 13G/A | | | | 1 | | ( (iv) Shared power to dispose or to direct the disposition of 661,056 [ re: Avenue Therapeutics, Inc. ] | 1 |
| 1/3/24 | | SC 13G | | | | 1 | | ( (iv) Shared power to dispose or to direct the disposition of 8,454,995,096 [ re: MMEX Resources Corp. ] | 1 |
| 1/3/24 | | SC 13G | | | | 1 | | ( (iv) Shared power to dispose or to direct the disposition of 844,654,010 [ re: MMEX Resources Corp. ] | 1 |
| 1/2/24 | | SC 13G/A | | | | 1 | | ( (iv) Shared power to dispose or to direct the disposition of 9,877 [ re: Bone Biologics Corp. ] | 1 |
| 1/2/24 | | SC 13G/A | | | | 1 | | ( (iv) Shared power to dispose or to direct the disposition of 930,905 [ re: Onconetix, Inc. ] | 1 |
| 1/3/24 | | SC 13G | | | | 1 | | ( (iv) Shared power to dispose or to direct the disposition of 97,305 [ re: Arcadia Biosciences, Inc. ] | 1 |
| 1/2/24 | | SC 13G/A | | | | 1 | | (iv) Shared power to dispose or to direct the disposition of 0 [ re: Cocrystal Pharma, Inc. ] | 1 |
| 1/2/24 | | SC 13G/A | | | | 1 | | (iv) Shared power to dispose or to direct the disposition of 0 [ re: Nisun International Enterprise Development Group Co., Ltd. ] | 1 |
| 1/2/24 | | SC 13G/A | | | | 1 | | (iv) Shared power to dispose or to direct the disposition of 0 [ re: Virpax Pharmaceuticals, Inc. ] | 1 |
| 1/2/24 | | SC 13G/A | | | | 1 | | (iv) Shared power to dispose or to direct the disposition of 22,048 [ re: Aditxt, Inc. ] | 1 |
